Luka from Germany

Registered at the short selling broker Skilling, 5 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Aurora Cannabis, Inc. (ACB) shares information

Aurora Cannabis Inc


24h Change

2.27 %

ACB

Live rate: Market closed

Stock data per Friday 1 Jul, 2022

ACB
NASDAQ
1.32
1.33
1.35
0.03 (+ 2.27%)
US Market is closed

Live Stock price in graph for Aurora Cannabis Inc (ACB)

  • Latest Volume

    4,668,642 (-38.67 %)

  • Volume prev. day

    7,612,051

  • Avg. daily volume

    9,607,168

  • Market cap

    401,975,893

  • P/E ratio

    -0.27

  • Today high

    1.38 USD

  • Today low

    1.3 USD

  • 52 week high

    8.86 USD

  • 52 week low

    1.21 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Aurora Cannabis Inc

Below you can find the most recent news posts about Aurora Cannabis Inc, primarily from US and UK based news sources.

Is Aurora Cannabis Too Cheap to Pass Up Right Now?

Thursday, 30 June 2022, 17:15:00
Some analysts have become more optimistic about the stock.
— The Motley Fool


Cannabis Stock Movers For June 29, 2022

Wednesday, 29 June 2022, 23:50:24
GAINERS: Cansortium (OTC: CNTMF ) shares closed up 4.07% at $0.17 Cara Therapeutics (NASDAQ: CARA ) shares closed up 3.67% at $9.60 Meridian Bioscience (NASDAQ: VIVO ) shares closed up 3.41% at $31.50 LOSERS: 22nd Century Group (NASDAQ: XXII ) shares closed down 12.55% at $2.02 Charlottes Web Holdings (OTC: CWBHF ) shares closed down 12.27% at $0.44 Auxly Cannabis Group (OTC: CBWTF ) shares closed down 8.71% at $0.06 Aurora Cannabis (NASDAQ: ACB ) shares closed down 8.05% at $1.37 ReneSola (NYSE: SOL ) shares closed down … Full story available on Benzinga.com
— Benzinga


Aurora Cannabis: Global Positioning Merits an Upgrade

Tuesday, 28 June 2022, 00:36:42
For a while now, the Canadian recreational cannabis market has been beset by a difficult operating environment while regulatory progress at the federal level in the…
— TipRanks


Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical

Monday, 27 June 2022, 16:45:51
Axsome Therapeutics Inc (NASDAQ: AXSM ) shares rallied 40% on Monday morning after the company received some positive news from the U.S. Food and Drug Administration regarding its AXS-05 novel treatment for MDD (depression). What Happened? Axsome filed an 8K on Monday morning reporting the FDA has proposed a product label for ASX-05. While the market”s initial reaction to the news was extremely positive, Bank of America analyst Jason Gerberry remains skeptical about ASX-05”s potential commercial success. Related Link: EXCLUSIVE: Aurora Cannabis CEO ”Absolutely Confident” Company Will Be EBITDA-Positive By Year”s End Why It”s Important: Gerberry has previously modeled a relatively high 70% probability of success for ASX-05. Following the latest update, Gerberry is now … Full story available on Benzinga.com
— Benzinga


Bullish Friday For Marijuana Stocks – Leviathan Natural Prods, Item 9 Labs Among Top Gainers

Friday, 24 June 2022, 23:02:28
GAINERS: Leviathan Natural Prods (OTC: LVCNF ) shares closed up 37.15% at $0.80 Item 9 Labs (OTC: INLB ) shares closed up 11.11% at $0.70 Charlottes Web Holdings (OTC: CWBHF ) shares closed up 10.64% at $0.52 Nine Energy Service (NYSE: NINE ) shares closed up 8.75% at $2.61 RIV Capital (OTC: CNPOF ) shares closed up 8.21% at $0.56 Aurora Cannabis (NASDAQ: ACB ) shares closed up 7.75% at $1.53 TerrAscend (OTC: TRSSF ) shares closed up 7.65% at $2.71 OrganiGram Holdings (NASDAQ: OGI ) shares closed up 7.52% at $1.06 4Front Ventures (OTC: Full story available on Benzinga.com
— Benzinga


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have ACB available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.